| (Values in U.S. Thousands) | Dec, 2022 | Sep, 2022 | Jun, 2022 | Mar, 2022 | Dec, 2021 |
| Sales | 0 | 61,130 | 68,540 | 59,130 | 54,830 |
| Sales Growth | unch | -10.81% | +15.91% | +7.84% | -2.99% |
| Net Income | 0 | -20,800 | -7,050 | -14,490 | 41,550 |
| Net Income Growth | unch | -195.04% | +51.35% | -134.87% | +341.43% |
Amryt Pharma Plc ADR (AMYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Amryt Pharma plc is a biopharmaceutical company. It develops and commercializes therapeutics to treat rare diseases. Amryt Pharma plc is based in London, the United Kingdom.
Fiscal Year End Date: 12/31